[1]Stanetty,Peter;Hattinger,Gregor;Schnuerch,Michael;Mihovilovic,MarkoD.[JournalofOrganicChemistry,2005,vol.70,#13,p.5215-5220]
[1]Stanetty,Peter;Hattinger,Gregor;Schnuerch,Michael;Mihovilovic,MarkoD.[JournalofOrganicChemistry,2005,vol.70,#13,p.5215-5220]
[2]Stanetty,Peter;Hattinger,Gregor;Schnuerch,Michael;Mihovilovic,MarkoD.[JournalofOrganicChemistry,2005,vol.70,#13,p.5215-5220]
[1]Stanetty,Peter;Hattinger,Gregor;Schnuerch,Michael;Mihovilovic,MarkoD.[JournalofOrganicChemistry,2005,vol.70,#13,p.5215-5220]
[2]Stanetty,Peter;Hattinger,Gregor;Schnuerch,Michael;Mihovilovic,MarkoD.[JournalofOrganicChemistry,2005,vol.70,#13,p.5215-5220]
[1]CurrentPatentAssignee:VICHEMCHEMIEKFT-US2008/187575,2008,A1Locationinpatent:Page/Pagecolumn30-31
Title: Identification of pyrimidine derivatives as hSMG-1 inhibitors.
Journal: Bioorganic & medicinal chemistry letters 20121101
Title: Expanding the diversity of allosteric bcr-abl inhibitors.
Journal: Journal of medicinal chemistry 20101014
Title: Microsphere-based protease assays and screening application for lethal factor and factor Xa.
Journal: Cytometry. Part A : the journal of the International Society for Analytical Cytology 20060501
Title: Novel and efficient access to phenylamino-pyrimidine type protein kinase C inhibitors utilizing a Negishi cross-coupling strategy.
Journal: The Journal of organic chemistry 20050624
Title: Synthesis and discovery of pyrazine-pyridine biheteroaryl as a novel series of potent vascular endothelial growth factor receptor-2 inhibitors.
Journal: Journal of medicinal chemistry 20050324
Title: A genome-wide overexpression screen in yeast for small-molecule target identification.
Journal: Chemistry & biology 20050101
Title: Jorda R, et al. How Selective Are Pharmacological Inhibitors of Cell-Cycle-Regulating Cyclin-Dependent Kinases?. J Med Chem. 2018;61(20):9105-9120.
Title: Han HW, et al. LINCS L1000 dataset-based repositioning of CGP-60474 as a highly potent anti-endotoxemic agent. Sci Rep. 2018;8(1):14969. Published 2018 Oct 8.
Title: Stanetty P, et al. Novel and efficient access to phenylamino-pyrimidine type protein kinase C inhibitors utilizing a Negishi cross-coupling strategy. J Org Chem. 2005;70(13):5215-5220.
